We estimated proportions (with 95% CIs) of adults who reported having used GLP-1 or GLP-1/GIP medication in the past year (a) for any reason, (b) to manage type 2 diabetes, (c) to reduce the risk of heart disease, (d) to support weight loss, and (e) exclusively to support weight loss (i.e
Haematological symptoms often appear first
*Correspondence: Panicos Shangaris [email protected] This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology These authors share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
BPC-157 Body Protection Compound-157 (BPC-157) is a peptidea short chain of amino acids
Targeted injectable therapies, such as semaglutide in Port St
They can also recommend ways to reduce any discomfort